Vertex Pharmaceuticals to buy US firm Exonics Therapeutics

This article was originally published here

Under the deal, Exonics equity holders will receive $245m (£192m) upfront payment from Vertex, as well as potential future payments based on the achievement of specified development and

The post Vertex Pharmaceuticals to buy US firm Exonics Therapeutics appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply